MetLife, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

ABN AMRO Bank N.V. Cuts Stake in MetLife, Inc. $MET - American Market News

AI-generated analysis

📉 ABN AMRO Bank N.V. cut its MetLife stake by 96.1%, selling 2,101,814 shares in the first quarter.

📈 Nordea Investment Management AB increased its holdings by 2.6% to own 4,630,165 shares valued at $366.5 million.

📈 Korea Investment CORP grew its position by 12.1%, adding 71,781 shares worth approximately $54.9 million.

📈 Wells Fargo raised its price target to $95.00 and maintained an 'overweight' rating on MetLife.

📈 Morgan Stanley increased its price objective to $93.00 with an 'overweight' rating in a May report.

📈 JPMorgan Chase upgraded its target price to $96.00 while keeping an 'overweight' stance.

📈 Weiss Ratings improved MetLife's rating from 'buy (b-)' to 'buy (b)' in mid-June.

📉 TD Cowen lowered its price target to $88.00 but maintained a 'buy' rating for the stock.

💰 MetLife reported quarterly EPS of $2.42, surpassing analyst estimates of $2.27.

📉 Revenue came in at $14.18 billion, missing the consensus forecast of $19.49 billion despite a 2.7% year-over-year increase.

💵 The company declared a quarterly dividend of $0.5925 per share, raising the annualized yield to 2.8%.

📊 MetLife achieved a return on equity of 22.60% and a net margin of 4.66% for the quarter.

📈 The stock trades at a PE ratio of 16.68 with a market capitalization of $55.38 billion.

📉 Revenue estimates were significantly higher than actuals, suggesting potential headwinds in specific business segments.

🏦 Institutional ownership remains high at 94.99%, indicating continued interest from major funds despite the ABN AMRO exit.

Bullish Signals
  • MetLife beat earnings per share expectations with a reported $2.42 EPS versus the consensus of $2.27.
  • Major analysts including Wells Fargo, Morgan Stanley, and JPMorgan Chase have raised price targets or maintained 'overweight' ratings.
  • The company increased its quarterly dividend to $0.5925 per share, boosting the annualized yield to 2.8%.
  • MetLife achieved a strong return on equity of 22.60% and generated positive revenue growth of 2.7% year-over-year.
  • Several institutional investors, such as Nordea and Korea Investment CORP, increased their stakes in the company.
Risk Factors
  • MetLife's quarterly revenue of $14.18 billion missed analyst estimates of $19.49 billion significantly.
  • ABN AMRO Bank N.V. drastically reduced its position by selling over 2.1 million shares, reducing holdings by 96.1%.
  • TD Cowen lowered its price target from $91.00 to $88.00 in a recent research note.
Full Analysis
ABN AMRO Bank N.V. significantly reduced its stake in MetLife, Inc. (NYSE:MET) by 96.1% during the first quarter, selling over 2.1 million shares and holding a remaining position valued at approximately $6.08 million. Conversely, several other institutional investors increased their holdings, including Nordea Investment Management AB, which grew its stake by 2.6%, and Korea Investment CORP, which added to its position by 12.1% in the third quarter. Analyst sentiment remains generally positive with major firms like Wells Fargo, Morgan Stanley, JPMorgan Chase, and Weiss Ratings raising their price targets or upgrading ratings to 'overweight' or 'buy'. The consensus target price stands at $95.62, reflecting a moderate buy rating from MarketBeat.com, though TD Cowen recently lowered its target to $88.00. MetLife reported strong quarterly earnings with EPS of $2.42, beating the consensus estimate of $2.27, and achieved a return on equity of 22.60%. However, revenue of $14.18 billion fell short of analyst expectations of $19.49 billion, though it grew 2.7% year-over-year. The company also increased its quarterly dividend to $0.5925 per share, offering a yield of 2.8%.